8
staff
Aneri Suthar
Aneri Suthar is a senior policy associate at FasterCures within the Milken Institute, where she c
onducts health policy analysis in areas related to Food and Drug Administration law, patient engagement, and biomedical innovation, and provides programmati
+ Read More
video
FasterCures: A Conversation with Michael Milken
article
FasterCures Quarterly Update: July 2023
In This Issue:
Convenings Recap
Policy Updates
FasterCures in the Media
FasterCures in the Communit
y
+ Read More
article
FasterCures Quarterly Update—October 2023
In This Newsletter
New Report: The Impact of Insight
Convenings Recap
Policy Updates: Pandemic and
All-Hazards Preparedness Act
+ Read More
report
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief
The Milken Institute Center for Public Health and FasterCures have identified three PAHPA 2023 poli
cy priorities that are core to improving and strengthening the nation’s biosecurity and preparedness infrastructure.
+ Read More
video
Implementing a Dynamic Venture Philanthropy Practice
How can nonprofit organizations develop and implement a venture philanthropy investment strategy?
article
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
Submitted electronically
Dr. Robert Califf
Commissioner
US Food and Drug Administration
Silver Spri
ng, MD 20993
Dear Dr. Califf,
+ Read More
article
Discussion Draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
Submitted electronically